Free Submission Public Relations &
Deutsch English

Regenerative Medicine Market in the US 2012-2016

United States regenerative medicine market: 15.8% CAGR between 2012-2016

Print article Print article
2014-01-31 04:55:01 - Regenerative Medicine Market in the US 2012-2016 - a new market research report on

The United States Regenerative Medicine market is to grow at a CAGR of 15.83 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of degenerative diseases. The Regenerative Medicine market in the US has also been witnessing an increasing number of mergers and acquisitions. However, stringent regulatory approval processes could pose a challenge to the growth of this market.

There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of artificial organs for implantation is expected to encourage many vendors and research organizations to develop advanced stem cell products, therapies, and regenerative products. It will also help reduce



the long organ waiting list. For instance, custom-made windpipe can be made using regenerative products within a week. The first ever implant of a synthetic trachea took place in June 2011. The synthetic trachea was made from minuscule plastic fibers and was covered in stem cells taken from a human bone marrow. Surgeons successfully implanted this synthetic trachea into a 36-year-old patient with late-stage tracheal cancer at Karolinska University Hospital in Stockholm. Thus, the use of synthetic organs in transplant surgeries is expected to have a positive impact on the growth of the market.

One of the main drivers of this market is the increasing prevalence of degenerative diseases. Regenerative products have helped in addressing the unmet needs of various disease areas. Another major driver of the market is the significant advances seen in R&D.

The stringent regulatory approval process for Regenerative products is one of the major challenges faced by the market. The stringent approval processes inhibits the entry of new products into the market.

The key vendors dominating this space include Baxter International Inc., Medtronic Inc., Stryker Corp., and Zimmer Holdings Inc.

The other vendors mentioned in the report are Advanced Cell Technology Inc., Athersys Inc., Arteriocyte Inc., Cytori Therapeutics Inc., CryoLife, Inc., Genzyme Corp., Geron Corp., Integra Life Sciences Holdings Corp., InVivo Therapeutics, Kensey Nash Corp., Kinetic Concepts Inc., NeoStem Inc., Osiris Therapeutics Inc., Osteotech Inc., and RTI Biologics Inc.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact